Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Oligonucleotide Synthesis Market 2021
2 August 2021
The global oligonucleotide synthesis market is set to grow by US$ 3.95 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 9.8% during the forecast period, according to data and analytics company StrategyHelix. Increase in R&D spending from pharmaceutical & biotechnology companies, rise in public & private spending on genomics, the use of synthesized oligonucleotides in molecular diagnostics and clinical applications are expected to boost the market growth in the coming years.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for oligonucleotide synthesis. The global oligonucleotide synthesis market is segmented on the basis of product, application, end user, and region. By product, it is categorized into oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, and services. The oligonucleotide drugs segment held the largest market share in 2020. By application, the oligonucleotide synthesis market is divided into diagnostics, therapeutics, and research. The research segment accounted for the largest market share in 2020. Based on end user, the oligonucleotide synthesis market is divided into pharmaceutical & biotechnology companies, diagnostic laboratories, and academic research institutes.
The report has profiled some of the key players of the market such as Agilent Technologies Inc., Biolegio BV, Biolytic Lab Performance Inc., Danaher Corporation, Eurofins Scientific SE, LGC Ltd., Merck KGaA, Microsynth AG, Thermo Fisher Scientific Inc..
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the oligonucleotide synthesis market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Product: oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, and services
Application: diagnostics, therapeutics, and research
End user: pharmaceutical & biotechnology companies, diagnostic laboratories, and academic research institutes
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global oligonucleotide synthesis market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Pinpoint growth sectors and trends for investment
Understand what the future of the global oligonucleotide synthesis market looks like
Identify the competitive landscape and window of opportunity
Table of Contents
1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Oligonucleotide Synthesis Market by Product
4.1 Oligonucleotide Drugs
4.2 Synthesized Oligonucleotides
5. Oligonucleotide Synthesis Market by Application
6. Oligonucleotide Synthesis Market by End User
6.1 Pharmaceutical & Biotechnology Companies
6.2 Diagnostic Laboratories
6.3 Academic Research Institutes
7. Oligonucleotide Synthesis Market by Region
7.1 North America
7.2 Asia Pacific
7.4 Rest Of The World (Row)
8. Company Profiles
8.1 Agilent Technologies, Inc.
8.2 Biolegio BV
8.3 Biolytic Lab Performance, Inc.
8.4 Danaher Corporation
8.5 Eurofins Scientific SE
8.6 LGC Ltd.
8.7 Merck KGaA
8.8 Microsynth AG
8.9 Thermo Fisher Scientific Inc.
9.1 About StrategyHelix